Published in J Clin Aesthet Dermatol on July 01, 2015
Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence | NCT00693420
The significance of the diurnal tension variations in normal and glaucomatous eyes. Arch Ophthalmol (1960) 1.82
Bimatoprost-induced periocular skin hyperpigmentation: histopathological study. Arch Ophthalmol (2005) 1.72
One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension. Arch Ophthalmol (2002) 1.70
Side effects associated with prostaglandin analog therapy. Surv Ophthalmol (2008) 1.69
Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psychooncology (2008) 1.65
The side effects of the prostaglandin analogues. Expert Opin Drug Saf (2007) 1.58
Diurnal intraocular pressure variations: an analysis of 690 diurnal curves. Br J Ophthalmol (1992) 1.50
Ocular complications of systemic cancer chemotherapy. Surv Ophthalmol (1990) 1.36
Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4. Br J Ophthalmol (2008) 1.24
Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost. Jpn J Ophthalmol (2011) 1.23
Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches. Support Care Cancer (2004) 1.16
A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension. Br J Ophthalmol (2003) 1.09
Bimatoprost in the treatment of eyelash hypotrichosis. Clin Ophthalmol (2010) 1.04
Bimatoprost: a novel antiglaucoma agent. Cardiovasc Drug Rev (2004) 1.02
Update on ocular complications of systemic cancer chemotherapy. Surv Ophthalmol (2006) 1.01
Long-term safety evaluation of bimatoprost ophthalmic solution 0.03%: a pooled analysis of six double-masked, randomized, active-controlled clinical trials. Clin Ophthalmol (2011) 0.93
Eyelash growth in subjects treated with bimatoprost: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study. J Am Acad Dermatol (2011) 0.93
Prostaglandin analogues in the anterior eye: their pressure lowering action and side effects. Exp Eye Res (2008) 0.90
Enhanced eyelashes: prescription and over-the-counter options. Aesthetic Plast Surg (2010) 0.86
Bimatoprost for eyelash growth in Japanese subjects: two multicenter controlled studies. Aesthetic Plast Surg (2014) 0.86
Management of hypotrichosis of the eyelashes: Focus on bimatoprost. Clin Cosmet Investig Dermatol (2010) 0.84
The role of bimatoprost eyelash gel in chemotherapy-induced madarosis: an analysis of efficacy and safety. Int J Trichology (2011) 0.81
Long-term safety and efficacy of bimatoprost solution 0·03% application to the eyelid margin for the treatment of idiopathic and chemotherapy-induced eyelash hypotrichosis: a randomized controlled trial. Br J Dermatol (2015) 0.78
A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis. Pediatr Dermatol (2015) 0.75
Safety and Efficacy of Bimatoprost for Eyelash Growth in Postchemotherapy Subjects. J Clin Aesthet Dermatol (2015) 0.75